ECDC Europa

ECDC Europa

Latest Posts

Weekly updates: 2024 West Nile virus transmission season​
Communicable disease threats report, 26 October – 1 November 2024, week 44​
Communicable disease threats report, 19-25 October 2024, week 43​
Communicable disease threats report, 5-11 October 2024, week 41​
Implications of the Marburg virus disease outbreak in Rwanda for the EU/EEA, 2024​
Epidemiological update, week 37/2024: Mpox due to monkeypox virus clade I​
Epidemiological update – Week 36/2024: Mpox due to monkeypox virus clade I​
Epidemiological update – Week 35/2024: Mpox due to monkeypox virus clade I​
Risk assessment for the EU/EEA of the mpox epidemic caused by monkeypox virus clade I in affected African countries​
Threat assessment brief: Oropouche virus disease cases imported to the European Union​
The European Respiratory Virus Surveillance Summary (ERVISS)​
Communicable disease threats report, 22-28 March 2025, week 13​
Weekly respiratory virus update, week 12, March 2025​
COVID-19 vaccination reduces risk of ‘long COVID’ in adults​
Does COVID-19 vaccination reduce the risk and duration of post COVID-19 condition?​
Communicable disease threats report, 15 – 21 March 2025, week 12​
Weekly respiratory virus update, week 11, March 2025​
Variable Sensitivity of SARS-CoV-2 Molecular Detection in European Expert Laboratories: External Quality Assessment, June and July 2020​
External quality assessment of SARS-CoV-2 serology in European expert laboratories, April 2021​
External quality assessments on COVID-19​